International Digital Health Symposium brings leaders together
Digital health leaders from around the globe have met at the inaugural International Digital Health Symposium in Sydney to learn from different global approaches...
Michigan Medicine offers surgery to restore eye sensation
Michigan Medicine surgeons are helping patients who have lost sensation in their regain feeling in their eye through a small-incision, nerve transplant procedure—corneal neurotization...
Elekta collaborates with Palabra to offer the industry’s only voice-enabled HER
Elekta announced that it is collaborating with Palabra, allowing one-of-a-kind speech integration and automation capabilities to be seamlessly integrated into Elekta’s MOSAIQ® Oncology Information...
Amblyopia and the brain
Vision occurs in the brain, not the eye. Our eyes convert light into a signal that the brain makes sense of, but sight actually...
MagVenture Ltd: New UK subsidiary offers non-pharmaceutical depression treatment and high-end solutions for brain...
MagVenture A/S, a global medical device company, has established a subsidiary in the UK. MagVenture specializes in magnetic stimulation, a technology used within the fields...
Poliovirus Therapy Induces Immune Responses Against Cancer
An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body’s own capacity to fight malignancies by activating an inflammation...
Cardiac SPECT solution at the American Society of Nuclear Cardiology’s Annual Scientific Session launched...
Royal Philips , a global leader in health technology, today announced its presence at the American Society of Nuclear Cardiology’s Annual Scientific Session in...
University of Washington researchers developed New app uses smartphone selfies to screen for pancreatic...
Pancreatic cancer has one of the worst prognoses  with a five-year survival rate of 9 percent in part because there are no telltale symptoms...
Cancer Research UK launches trial to test new drug in patients with advanced cancer
A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres* across the UK, through Cancer...
PCSK9 inhibition could ameliorate cardiovascular disease by immune mechanisms
PCSK9 inhibition could ameliorate atherosclerosis and thus cardiovascular disease by immune mechanisms that are unrelated to lowering of low-density lipoprotein (LDL) cholesterol, according to...
